Search - tctmd.com

Displaying 41 - 60 of 343

Sort: Relevancy | Date

Presentation THT 2025

Alleviant Implant Free Shunt: Learning and Adapting in Device and Trial Design

Presenter: James Udelson

February 12, 2025

Presentation THT 2025

Adona Shunt: Adjustable Shunt With Built in Pressure Sensors

Presenter: Liviu Klein

February 12, 2025

Presentation THT 2025

HFpEF in Focus: The Scientific Rationale for the Confirmatory RESPONDER HF Trial

Presenter: Sanjiv Shah

February 12, 2025

Presentation THT 2025

Interatrial Shunting for HF: Different Devices, Different Populations, Different Results

Presenter: Sheldon Litwin

February 12, 2025

Presentation THT 2025

INTERSHUNT: Leave No Device Behind

Presenter: Saibal Kar

February 12, 2025

Presentation THT 2025

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Presenter: Gregg W. Stone

February 11, 2025

Presentation THT 2025

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Presenter: Stefan Anker

February 11, 2025

Presentation THT 2025

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Presenter: Barry Borlaug

February 11, 2025

Presentation Miami Valves 2025

Left Atrium to Coronary Sinus Shunting: Edwards’ APTURE shunt and ALT-FLOW II trial status

Presenter: Santiago Garcia

January 30, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

Presentation TCT 2024

TCT 112: The Association Between Residual Shunt and the Endothelialization of the Closure Devices for Patent Foramen Ovale (PFO) 12 Months After Implantation Evaluated by Angioscopy

Presenter: Kazuki Muramatsu

October 29, 2024

Presentation TCT 2024

Interatrial Shunts (IASD): From Theory to Clinical Trials

Presenter: Javed Butler

October 28, 2024

Presentation TCT 2024

TCT 468: No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly-Reduced Ejection Fraction: Twelve-Month Outcomes From Multi-Center Pilot Feasibility Studies

Presenter: Brian Potter

October 28, 2024

News Daily News

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

L.A. McKeown

October 15, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

Presentation NY Valves 2024

Safety, Efficacy, and Long Term Outcomes With Using Pre-Procedural Predictive Modeling for Left Atrial Appendage Closure Preplanning

Presenter: Kirollos Gabrah

June 05, 2024

Presentation NY Valves 2024

Treatment of Residual Shunt After PFO Closure Using Mullins Sheath-Facilitated Delivery of the Gore Cardioform Septal Occluder Device

Presenter: Francesca Isabella Galasso

June 05, 2024

Advertisement

Alleviant Implant Free Shunt: Learning and Adapting in Device and Trial Design

Adona Shunt: Adjustable Shunt With Built in Pressure Sensors

HFpEF in Focus: The Scientific Rationale for the Confirmatory RESPONDER HF Trial

Interatrial Shunting for HF: Different Devices, Different Populations, Different Results

INTERSHUNT: Leave No Device Behind

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Left Atrium to Coronary Sinus Shunting: Edwards’ APTURE shunt and ALT-FLOW II trial status

Top Heart Failure News of 2024

TCT 112: The Association Between Residual Shunt and the Endothelialization of the Closure Devices for Patent Foramen Ovale (PFO) 12 Months After Implantation Evaluated by Angioscopy

Interatrial Shunts (IASD): From Theory to Clinical Trials

TCT 468: No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly-Reduced Ejection Fraction: Twelve-Month Outcomes From Multi-Center Pilot Feasibility Studies

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Safety, Efficacy, and Long Term Outcomes With Using Pre-Procedural Predictive Modeling for Left Atrial Appendage Closure Preplanning

Treatment of Residual Shunt After PFO Closure Using Mullins Sheath-Facilitated Delivery of the Gore Cardioform Septal Occluder Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content